Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Refined saddle-point preconditioners for discretized Stokes problems.

Pearson JW, Pestana J, Silvester DJ.

Numer Math (Heidelb). 2018;138(2):331-363. doi: 10.1007/s00211-017-0908-4. Epub 2017 Jul 25.

2.

Fast interior point solution of quadratic programming problems arising from PDE-constrained optimization.

Pearson JW, Gondzio J.

Numer Math (Heidelb). 2017;137(4):959-999. doi: 10.1007/s00211-017-0892-8. Epub 2017 May 22.

3.

Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.

Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL.

J Natl Cancer Inst. 1996 Jun 5;88(11):747-53.

PMID:
8637029
4.

Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.

Fogler WE, Pearson JW, Volker K, Ariyoshi K, Watabe H, Riggs CW, Wiltrout RH, Longo DL.

J Natl Cancer Inst. 1995 Jan 18;87(2):94-104.

PMID:
7707396
5.
6.

Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line.

Dickstein B, Valverius EM, Wosikowski K, Saceda M, Pearson JW, Martin MB, Bates SE.

J Cell Physiol. 1993 Oct;157(1):110-8.

PMID:
8408230
7.

Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.

Pearson JW, Fogler WE, Volker K, Riggs CW, Gruys E, Groves ES, Wiltrout RH, Longo DL.

J Natl Cancer Inst. 1993 Jun 2;85(11):907-12.

PMID:
8492319
8.
9.

Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.

Pearson JW, Fogler WE, Volker K, Usui N, Goldenberg SK, Gruys E, Riggs CW, Komschlies K, Wiltrout RH, Tsuruo T, et al.

J Natl Cancer Inst. 1991 Oct 2;83(19):1386-91.

PMID:
1681110
10.

Endocervical brush for Papanicolau smears: adverse effects or contraindications to use.

Pearson JW.

JAMA. 1991 May 8;265(18):2409. No abstract available.

PMID:
2016841
11.

Immunoconjugates of Pseudomonas exotoxin A: evaluation in mice, monkeys, and man.

Morgan AC Jr, Manger R, Pearson JW, Longo D, Abrams P, Sivam G, Bjorn M.

Cancer Detect Prev. 1991;15(2):137-43. Review.

PMID:
2032255
12.

Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.

Pearson JW, Hedrick E, Fogler WE, Bull RL, Ferris DK, Riggs CW, Wiltrout RH, Sivam G, Morgan AC, Groves E, et al.

Cancer Res. 1990 Oct 1;50(19):6379-88.

13.

Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.

Pearson JW, Sivam G, Manger R, Wiltrout RH, Morgan AC Jr, Longo DL.

Cancer Res. 1989 Sep 15;49(18):4990-5.

14.

Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.

Pearson JW, FitzGerald DJ, Willingham MC, Wiltrout RH, Pastan I, Longo DL.

Cancer Res. 1989 Jul 1;49(13):3562-7.

15.

Observation: a useful tool or a relic from the past?

Pearson JW.

Hawaii Med J. 1988 Aug;47(8):369-71, 389. No abstract available.

PMID:
3170180
16.

Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.

Sivam G, Pearson JW, Bohn W, Oldham RK, Sadoff JC, Morgan AC Jr.

Cancer Res. 1987 Jun 15;47(12):3169-73.

17.

Immunotoxins to a human melanoma-associated antigen: resistance to pokeweed antiviral protein conjugates in vitro.

Morgan AC Jr, Bordonaro J, Pearson JW, Sivam G.

J Natl Cancer Inst. 1987 Jun;78(6):1101-6.

PMID:
3473251
18.

Plasma endorphin-like immunoreactivity in pelvic and abdominal pain.

Bennett TL, Pearson JW, Frederickson RC.

Pain. 1986 Jan;24(1):41-8.

PMID:
2937005
19.

The role of midforceps in current obstetric practice.

Pearson JW.

Am J Obstet Gynecol. 1985 Jul 1;152(5):606. No abstract available.

PMID:
4014362
20.

Endorphins and parturition.

Detrick JM, Pearson JW, Frederickson RC.

Obstet Gynecol. 1985 May;65(5):647-51.

PMID:
3157077
22.

Outpatient intravenous heparin.

Pearson JW.

Am J Obstet Gynecol. 1984 May 1;149(1):108-9. No abstract available.

PMID:
6720768
23.

Tumor models to investigate the therapeutic efficiency of immunomodulators.

Talmadge E, Lenz BF, Collins MS, Uithoven KA, Schneider MA, Adams JS, Pearson JW, Agee WJ, Fox RE, Oldham RK.

Behring Inst Mitt. 1984 May;(74):219-29.

PMID:
6477354
24.

Cesarean section and perinatal mortality. A nine-year experience in a city/county hospital.

Pearson JW.

Am J Obstet Gynecol. 1984 Jan 15;148(2):155-9.

PMID:
6691391
25.

Treatment of canine transmissible venereal tumor by intravenous administration of protein A.

Cohen D, Fer MF, Pearson JW, Herberman RB.

J Biol Response Mod. 1984;3(3):271-7.

PMID:
6747669
26.

Busulfan versus cyclophosphamide treatment in the early and late stages of granulocytic leukemia in guinea pigs.

Evans WH, Miller DA, Pearson JW, Smalley RV, Moore DE, Terebelo HK.

Leuk Res. 1984;8(6):1037-42.

PMID:
6595477
27.

Neuropathy following paracervical block in the obstetric patient.

Gaylord TG, Pearson JW.

Obstet Gynecol. 1982 Oct;60(4):521-4.

PMID:
7121939
28.

Inhibition of rat adenocarcinoma metastases by "Staphylococcus aureus" protein A.

Cowan FM, Klein DL, Armstrong GR, Ablashi DV, Pearson JW, Bensinger WI.

Biomed Pharmacother. 1982 Jan;36(1):29-31.

PMID:
7126768
29.

Fc receptor mediated immune regulation and gene expression.

Cowan FM, Klein DL, Armstrong GR, Stylos WA, Pearson JW.

Biomedicine. 1980 Oct;32(3):108-10. Review.

PMID:
7004510
30.

The use of immunotherapy to enhance tumor rejection immunity in leukemic (L2C) guinea pigs following remission induction with MeCCNU.

Klein DL, Cote P, Garner W, Wallen RM, Pearson JW.

Leuk Res. 1980;4(1):185-95. No abstract available.

PMID:
7412356
31.

Macrophage cytostasis and T and B cell blastogenic transformation in mice treated with nystatin.

Klein DL, Aszalos A, Pearson JW.

J Immunopharmacol. 1980;2(3):367-80.

PMID:
6821559
32.

Suppression of DNA synthesis in mitogen stimulated leukocytes with partial trypsin digests of Staphylococcus aureus protein A.

Cowan FM, Klein DL, Armstrong GR, Stylos WA, Pearson JW.

Biomedicine. 1979 Dec;31(8):220-3.

PMID:
534678
33.

Augmentation and inhibition of delayed hypersensitivity by Staphylococcus aureus protein A.

Cowan FM, Klein DL, Armstrong GR, Pearson JW.

Biomedicine. 1979 Nov;30(5):241-4.

PMID:
518957
34.

Positive rubella titers in pregnancy: a question of validity.

Hall JA, Wills ER, Hall K, Pearson JW.

Obstet Gynecol. 1979 Aug;54(2):235-6.

PMID:
460760
35.

Recertification in obstetrics and gynecology.

Pearson JW.

Clin Obstet Gynecol. 1979 Mar;22(1):1-8. No abstract available.

PMID:
376194
36.
37.

Isolation and characterization of a spontaneous lymphocytic leukemia (L-76) in the strain 2 guinea pig.

Klein DL, Perk K, Dahlberg JE, Brown W, Pearson JW.

Cancer Res. 1978 Oct;38(10):3154-60. No abstract available.

38.

Modulation of host immune response against the L2C guinea pig leukemia.

Klein DL, Pearson JW.

Fed Proc. 1977 Aug;36(9):2276-80. No abstract available.

PMID:
885264
39.

Histological and combined chemoimmunostimulation therapy studies against a murine leukemia.

Pearson JW, Perk K, Chirigos MA, Pryor JW, Fuhrman FS.

Int J Cancer. 1975 Jul 15;16(1):142-52.

PMID:
170212
40.

Drug therapy against a transplantable guinea pig leukemia.

Pearson JW, Perk K, Chirigos MA, Torgersen JA.

Cancer Res. 1975 Apr;35(4):1093-8.

41.

The obstetrician and gynecologist. Primary physician for women.

Pearson JW.

JAMA. 1975 Feb 24;231(8):815-6. No abstract available.

PMID:
234161
42.

The management of high-risk pregnancy.

Pearson JW.

JAMA. 1974 Sep 9;229(11):1439-40. No abstract available.

PMID:
4408384
43.

An animal model for meningeal leukemia.

Perk K, Pearson JW, Torgersen JA, Chirigos MA.

Int J Cancer. 1974 Jun 15;13(6):863-6. No abstract available.

PMID:
4527649
44.

Nonimmunologic hydrops fetalis. Report of two cases.

Turbeville DF, Killam AP, Davis PC Jr, Heath RE Jr, Fearnow RG, Pearson JW.

Obstet Gynecol. 1974 Apr;43(4):567-70. No abstract available.

PMID:
4817008
45.

Combined drug and immunostimulation therapy against a syngeneic murine leukemia.

Pearson JW, Chirigos MA, Chaparas SD, Sher NA.

J Natl Cancer Inst. 1974 Feb;52(2):463-8. No abstract available.

PMID:
4593139
46.

The effect of drug therapy against a histologically defined rat leukemia.

Pearson JW, Chaparas SD, Torgersen JA, Perk K, Chirigos MA, Sher NA.

Cancer Res. 1974 Feb;34(2):355-61. No abstract available.

47.

Effect of three strains of BCG against a murine leukemia after drug therapy.

Sher NA, Pearson JW, Chaparas SD, Chirigos MA.

J Natl Cancer Inst. 1973 Dec;51(6):2001-3. No abstract available.

PMID:
4587756
48.

Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.

Chirigos MA, Pearson JW, Pryor J.

Cancer Res. 1973 Nov;33(11):2615-8. No abstract available.

49.

Brief communication: Cure of murine leukemia with drug and interferon treatment.

Chirigos MA, Pearson JW.

J Natl Cancer Inst. 1973 Oct;51(4):1367-8. No abstract available.

PMID:
4745868
50.

Letter: Fetal bleeding.

Crystle CD, Rigsby WC, Ryan GT, Pearson JW.

Obstet Gynecol. 1973 Oct;42(4):626. No abstract available.

PMID:
4742671

Supplemental Content

Loading ...
Support Center